My HPRA: Register

FLIXONASE ALLERGY RELIEF

50 Microgram Nasal Spray Suspension

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/095/001

Main Information

Trade NameFLIXONASE ALLERGY RELIEF
Active SubstancesFLUTICASONE PROPIONATE
Strength50 Microgram
Dosage FormNasal Spray Suspension
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/095/001

Group Information

ATC CodeR01AD08 Corticosteroids

Status

Authorised/WithdrawnAuthorised
Licence Issued02/05/2003
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusMarketed
Promotion StatusPromotion to the general public
Conditions of LicenceRetail through pharmacies and promotion to the public if compliant with the following restrictions: pack containing not more than 3,000 mcg fluticasone proprionate, maximum period of treatment: 6 months, maxiumum dose: 100 mcg per nostril, maximum daily dose: 200 mcg per nostril, limited indications, pharmaceutical form: non-pressurised nasal spray, for use in adults only.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.